Skip to content
Loading…
A record surge in Moderna Inc.’s shares delivered a $5 billion blow to short sellers who had bet that the vaccine maker’s years-long slump would continue.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.